Sign inJoin waitlistJoin the waitlist

Dean Kellogg

Physician · Tahoe Forest MultiSpecialty Clinics

Credentials: · · ·

History

Tahoe Forest MultiSpecialty Clinics
2025–Present

Research

Biological aging processes underlying cognitive decline and neurodegenerative disease
Review · Journal of Clinical Investigation · 2022 · 307 citations
Cutaneous vasodilator and vasoconstrictor mechanisms in temperature regulation
Review · Comprehensive physiology · 2014 · Last of 3 authors · 274 citations
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility…
EBioMedicine · 2023 · 238 citations

Michelle Trbovich
7 papers · 1 as a fellow
Anoop Nambiar
5 papers
YW
Yubo Wu
5 papers · 2 as a fellow
Nicolas Musi
3 papers
Jay Peters
2 papers
Marcos Restrepo
2 papers
MG
Mitzi Gonzales
2 papers
NL
Nathan LeBrasseur
2 papers
Alain Bertoni
1 paper
Alfredo Urdaneta
1 paper
Ambarish Pandey
1 paper
Anand Prasad
1 paper

Grants

RESTOR [Rapamycin and Everolimus Study Towards Older Rejuvenation]: An Exploratory PK/PD Study of mTOR Inhibition in Older Human Subjects
National Institute on Aging · U01
PI · $2.3M · University of Texas Hlth Science Center
2024–2029
An Innovative Proof-of-Concept Approach to Identify Age-Modulating Drugs Capable of Reversing Inflammation and Re-Setting the Epigenetic Clock
National Institute on Aging · R21
PI · $424.4K · University of Texas Hlth Science Center
2020–2024
Elucidating Sympathetic Vasoconstrictor Mechanisms of Autonomic Dysreflexia in Persons with Spinal Cord Injury
Department of Veterans Affairs · I21
Contact PI · South Texas Veterans Health Care System
2021–2023
TRPV1 Mediation of Local Vasoconstrictor Reflexes in Spinal Cord Injured Humans
National Institute of Neurological Disorders and Stroke · R03
Contact PI · $125.4K · University of Texas Hlth Science Center
2013–2017

Clinical trials

Effect of mTOR Inhibition & Other Metabolism Modulating Interventions on the Elderly [SubStudy Rapa & cMRI to Evaluate Cardiac Function]
Principal investigator · Active not recruiting · Phase 2
The University of Texas Health Science Center at San Antonio
2022–2026
Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock
Principal investigator · Completed · Early phase 1
The University of Texas Health Science Center at San Antonio
2021–2022
Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS
Principal investigator · Withdrawn · Phase 1, Phase 2
The University of Texas Health Science Center at San Antonio
2021–2023
RAPA-Keloid Study of Keloid Regression
Principal investigator · Completed · Early phase 1
The University of Texas Health Science Center at San Antonio
2020–2021